Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2010-3-15
pubmed:abstractText
Post-translational modification and degradation of proteins by the ubiquitin-proteasome system are key regulatory mechanisms in cellular responses to various stimuli. The NF-kappaB signaling pathway is controlled by the ubiquitin-mediated proteolysis. RelA/p65, which is a main subunit of NF-kappaB, is ubiquitinated for degradation by SOCS-1, but the functional mechanism of its ubiquitination remains poorly understood. In this study we show that phosphorylation of RelA/p65 at Ser276 prevents its degradation by ubiquitin-mediated proteolysis. In contrast, impairment of Ser276 phosphorylation affects constitutive degradation of RelA/p65. Importantly, we identify Pim-1 as a further kinase responsible for the phosphorylation of RelA/p65 at Ser276. Depletion of Pim-1 hinders not only Ser276 phosphorylation but also transactivation of RelA/p65 target genes. We also show that Pim-1 contributes to recruitment of RelA/p65 to kappaB-elements to activate NF-kappaB signalling after TNF-alpha stimulation. In concert with these results, the knockdown of Pim-1 impairs IL-6 production and augments apoptosis by interfering RelA/p65 activation. These findings provide a model in which Pim-1 phosphorylation of RelA/p65 at Ser276 allows defense against ubiquitin-mediated degradation and whereby exerts activation of NF-kappaB signalling.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1476-5403
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
17
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
689-98
pubmed:meshHeading
pubmed-meshheading:19911008-Amino Acid Sequence, pubmed-meshheading:19911008-Animals, pubmed-meshheading:19911008-Apoptosis, pubmed-meshheading:19911008-COS Cells, pubmed-meshheading:19911008-Cercopithecus aethiops, pubmed-meshheading:19911008-Down-Regulation, pubmed-meshheading:19911008-Gene Expression Regulation, pubmed-meshheading:19911008-HeLa Cells, pubmed-meshheading:19911008-Humans, pubmed-meshheading:19911008-Interleukin-6, pubmed-meshheading:19911008-NF-kappa B, pubmed-meshheading:19911008-Phosphorylation, pubmed-meshheading:19911008-Proto-Oncogene Proteins c-pim-1, pubmed-meshheading:19911008-RNA Interference, pubmed-meshheading:19911008-Serine, pubmed-meshheading:19911008-Signal Transduction, pubmed-meshheading:19911008-Transcription Factor RelA, pubmed-meshheading:19911008-Transcriptional Activation, pubmed-meshheading:19911008-Tumor Necrosis Factor-alpha, pubmed-meshheading:19911008-Ubiquitin
pubmed:year
2010
pubmed:articleTitle
Pim-1 controls NF-kappaB signalling by stabilizing RelA/p65.
pubmed:affiliation
Department of Molecular Genetics, Medical Research Institute, Tokyo Medical and Dental University, Yushima 1-5-45, Bunkyo-ku, Tokyo 113-8510, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't